Ximelagatran--promises and concerns

JAMA. 2005 Feb 9;293(6):736-9. doi: 10.1001/jama.293.6.736.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy
  • Azetidines / therapeutic use*
  • Benzylamines
  • Clinical Trials as Topic
  • Coronary Artery Disease / prevention & control
  • Humans
  • Prodrugs / therapeutic use*
  • Risk
  • Stroke / etiology
  • Stroke / prevention & control
  • Venous Thrombosis / prevention & control

Substances

  • Anticoagulants
  • Azetidines
  • Benzylamines
  • Prodrugs
  • ximelagatran